Thyrotropin-dependent proliferation of in vitro rat thyroid cell systems

European Journal of Endocrinology

Volumn 143, Issue 2, 2000, Pages 161-178

  Medina, D L ^a   Santisteban, P ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; GUANOSINE TRIPHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; THYROTROPIN;

ANIMAL CELL; CELL GROWTH; CELL PROLIFERATION; HORMONE ACTION; MITOGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SIGNAL TRANSDUCTION; THYROID CELL;

EID: 0033867435     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1430161     Document Type: Review

References (265)

1. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4
2. p15INK4b Is a potential effector of TGFb-induced cell cycle arrest
3. Growth suppression by p18, a p16INK4/MTS1- and p15INK4b/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function
4. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6
5. Identification of human/mouse p19, a novel CDK4/CDK6 inhibitor with homology to p16ink4
6. CDK inhibitors: Positive and negative regulators of G1-phase progression
7. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit
8. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
9. WAF1, a potential mediator of p53 tumor suppression
10. p21 Is a universal inhibitor of cyclin kinases
11. p53-Dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest
12. Cloning of senescent cell-derived inhibitors of DNA-synthesis using an expression screen
13. p27Kip1, a cyclin-cdk inhibitor links transforming growth factor-β and contact inhibition to cell cycle arrest
14. p27, A novel inhibitor of G1 cyclin/cdk protein kinase activity, is related to p21
15. Cloning of p57Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution
16. p57Kip2, a structurally distinct member of the p21CIP1 cdk inhibitor family, is a candidate tumor suppressor gene
17. Separate domains of p21 involved in the inhibition of cdk kinase and PCNA
18. Cyclin-binding motifs are essential for the function of p21Cip1
19. Identification of the active region of the DNA-synthesis inhibitory gene p21Sdi1/CIP1/WAF1
20. A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent inhibitor p21WAF1 and proliferating cell nuclear antigen
21. Analysis of wild-type and mutant p21WAF1 gene activities
22. Crystal structure of the p27Kip1 cyclin-dependent kinase inhibitor bound to the cyclin A-cdk2 complex
23. Culture of hormone-dependent functional cells of rat thyroid
24. Insulin stimulates cell growth of a new strain of differentiated rat thyroid cells
25. One- and two-step transformation of rat thyroid epithelial cells by retroviral oncogenes
26. 3',5'-Cyclin adenosine monophosphate-regulated enhancer binding (CREB) activity is required for normal growth and differentiated phenotype in the FRTL-5 thyroid follicular cell line
27. The isolation and culture of thyroid cells
28. Thyrotropin effects on thyroid cells in culture. Effects of trypsin on the thyrotropin receptor and on thyrotropin-mediated cyclic 3':5'-AMP changes
29. Clonal stability and phenotypic expression of chick cartilage cells in vitro
30. Replacement of serum by hormones permits growth of cells in a defined medium
31. Thyrotropin induces changes in the morphology and the organization of microfilament structures in cultured thyroid cells
32. The relationship of growth and adenylate cyclase activity in cultured thyroid cells: Separate bioeffects of thyrotropin
33. Characterization of the optimal stimulatory effects of Graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in FRTL-5 thyroid cells: A potential clinical assay
34. Iodide transport in a continuous line of cultured cells from rat thyroid
35. Growth factor control of rat thyroid follicular cell proliferation
36. Insulin and TSH promote growth in size of PC C13 rat thyroid cells, possibly via a pathway different from DNA synthesis: Comparison with FRTL-5 cells
37. Thyrotropin dependent and independent thyroid cell lines selected from FRTL-5 derived tumors grown in nude mice
38. Comparison of FRTL-5 cell growth in vitro with that of xenotransplanted cells and the thyroid of the recipient mouse
39. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and others growth factors
40. Somatostatin is expressed in FRTL-5 thyroid cells and prevents thyrotropin-mediated down-regulation of the cyclin-dependent kinase inhibitor p27kip1
41. Mutations of thyrotropin receptor gene
42. Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function
43. G proteins. The subunit story thickens
44. Evidence that adenosine 3',5'-monophosphate mediates stimulation of thyroid growth in FRTL5 cells
45. The thyrotropin receptor and the regulation of thyrocyte function and growth
46. The level of thyroglobulin mRNA is regulated by TSH both in vitro and in vivo
47. Thyrotropin and dibutyryl cyclic AMP increase levels of c-myc and c-fos mRNAs in cultured rat thyroid cells
48. Control of c-fos and c-myc proto-oncogene induction in rat thyroid cells in culture
49. Inhibition of thyrotropin-induced DNA synthesis in thyroid follicular cells by microinjection of an antibody to the stimulatory G protein of adenylate cyclase, Gs
50. Genetic alterations in thyroid hyperfunctioning adenomas
51. Presence of nonfunctional thyrotropin receptor variant transcripts in retroocular and other tissues
52. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas
53. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism
54. Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters
55. A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism
56. Oncogenic mutations in thyroid adenoma: Methodological criteria
57. 2+ cascades
58. Oncogenic potential of a mutant human thyrotropin receptor expressed in FRTL-5 cells
59. 12. Thyroglobulin gene expression is regulated by insulin and insulin-like growth factor I (IGF-I) as well as thyrotropin in FRTL-5 thyroid cells
60. Insulin-like growth factor-I stimulates growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves-IgG
61. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes
62. Insulin signal transduction and the IRS proteins
63. A mutant insulin receptor induces formation of a Shc-growth factor receptor bound protein 2 (Grb2) complex and p21ras-GTP without detectable interaction of insulinreceptor substrate 1 (IRS1) with Grb2. Evidence for IRS1-independent p21ras-GTP formation
64. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: Implications for insulin control of ras signalling
65. Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation
66. Thyrotropin-induced elevation of 1,2-diacylglycerol and stimulation of growth of FRTL-5 cells are not dependent on inositol lipid hydrolysis
67. Independent and interactive effects of tetradecanoyl phorbol acetate on growth and differentiated functions of FRTL5 cells
68. 2+ influx induced by a combination of thyrotropin and insulin-like growth factor-I in rat thyroid cells
69. Opposite regulation of deoxyribonucleic acid synthesis and iodide uptake in rat thyroid cells by basic fibroblast growth factor: Correlation with opposite regulation of c-fos and thyrotropin receptor gene expression
70. Demonstration of the production and physiological role of insulin-like growth factor II in rat thyroid follicular cells in culture
71. Basic fibroblast growth factor: An autocrine mitogen of rat thyroid follicular cells?
72. Growth regulation of rat thyrocytes (FRTL-5 cells) by the secreted ectodomain of beta-amyloid precursor-like proteins
73. Inhibition by islet-activating protein, pertussis toxin, of P2-purinergic receptor-mediated iodide efflux and phosphoinositide turnover in FRTL-5 cells
74. 2+-dependent manner in FRTL-5 thyroid cell membranes
75. 2+ mobilization by thyrotropin, carbachol, and adenosine triphosphate in dog thyroid cells
76. 2+)-phosphatidylinositol cascade of human thyrocytes in primary culture
77. Purinergic agonist ATP is a comitogen in thyroid FRTL-5 cells
78. Sphingosine 1-phosphate mobilizes sequestered calcium, activates calcium entry, and stimulates deoxyribonucleic acid synthesis in thyroid FRTL-5 cells
79. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease
80. A Drosophila gene encoding a protein resembling the human beta-amyloid protein precursor
81. Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides
82. Iodine inhibits the proliferation of rat thyroid cells in culture
83. Evidence that the inhibitory effects of iodide on thyroid cell proliferation are due to arrest of the cell cycle at G0-G1 and G2-M phases
84. Transforming growth factor-beta in disease: The dark side of tissue repair
85. Transforming growth factor-beta 1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease
86. General inhibition by transforming growth factor beta 1 of thyrotropin and cAMP responses in human thyroid cells in primary culture
87. Thyrotropin-dependent transforming growth factor beta expression in thyroid gland
88. Growth factors and goitrogenesis
89. Enhanced expression of transforming growth factor-beta 1 during thyroid hyperplasia in rats
90. Transforming growth factor-beta blocks protein kinase-A-mediated iodide transport and protein kinase-C-mediated DNA synthesis in FRTL-5 rat thyroid cells
91. The effects of transforming growth factor-beta on growth and differentiation of the continuous rat thyroid follicular cell line, FRTL-5
92. TGF beta1 actions on FRTL-5 cells provide a model for the physiological regulation of thyroid growth
93. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone
94. Somatostatin
95. Single cellular origin of somatostatin and calcitonin in the rat thyroid gland
96. Somatostatin inhibits deoxyribonucleic acid synthesis induced by both thyrotropin and insulin-like growth factor-I in FRTL5 cells
97. Somatostatin inhibits PC Cl3 thyroid cell proliferation through the modulation of phosphotyrosine activity. Impairment of the somatostatinergic effects by stable expression of E1A viral oncogene
98. Somatostatin receptors
99. Induction of a negative autocrine loop by expression of sst2 somatostatin receptor in NIH 3T3 cells
100. Somatostatin regulates somatostatin receptor subtype mRNA expression in GH3 cells
101. The genetic subtypes of cAMP-dependent protein kinase - Functionally different or redundant?
102. Expression of a kinase anchor protein 75 depletes type II cAMP-dependent protein kinases from the cytoplasm and sequesters the kinases in a particulate pool
103. Rapid and reversible translocation of the catalytic subunit of cAMP-dependent protein kinase type II from the Golgi complex to the nucleus
104. Identification of a high affinity binding protein for the regulatory subunit RII beta of cAMP-dependent protein kinase in Golgi enriched membranes of human lymphoblasts
105. Phosphorylation of the regulatory subunit of type II beta cAMP-dependent protein kinase by cyclin B/p34cdc2 kinase impairs its binding to microtubule-associated protein 2
106. High affinity binding protein for the regulatory subunit of cAMP-dependent protein kinase II-B. Cloning, characterization, and expression of cDNAs for rat brain P150
107. cAMP signaling in neurons: Patterns of neuronal expression and intracellular localization for a novel protein, AKAP 150, that anchors the regulatory subunit of cAMP-dependent protein kinase II beta
108. Cloning and expression of an intron-less gene for AKAP 75, an anchor protein for the regulatory subunit of cAMP-dependent protein kinase II beta
109. Localization of A-kinase through anchoring proteins
110. cAMP-dependent protein kinase: Framework for a diverse family of regulatory enzymes
111. Structure and function of cyclic nucleotide-dependent protein kinases
112. Comparison of adenosine 3':5'-monophosphate-dependent protein kinases from rabbit skeletal and bovine heart muscle
113. Overexpression of the type II regulatory subunit of the cAMP-dependent protein kinase eliminates the type I holoenzyme in mouse cells
114. cAMP-dependent protein kinases I and II: Divergent turnover of subunits
115. Cyclin AMP stimulates somatostatin gene transcription by phosphorylation of CREB at Ser-133
116. Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A
117. A refractory phase in cyclic AMP-responsive transcription requires down regulation of protein kinase A
118. Pairs of cyclic AMP analogs, that are specifically synergistic for type I and type II cAMP-dependent protein kinases, mimic thyrotropin effects on the function, differentiation expression and mitogenesis of dog thyroid cells
119. Thyroid-stimulating hormone-regulated growth and cell cycle distribution of thyroid cells involve type I isozyme of cyclic AMP-dependent protein kinase
120. Inhibition of thyrotropin-stimulated DNA synthesis by microinjection of inhibitors of cellular Ras and cyclic AMP-dependent protein kinase
121. Thyroid-specific gene expression
122. Activation of cyclic AMP-dependent kinase is required but may not be sufficient to mimic cyclic AMP-dependent DNA synthesis and thyroglobulin expression in dog thyroid cells
123. v-Ras and protein kinase C dedifferentiate thyroid cells by down-regulating nuclear cAMP-dependent protein kinase A
124. Ki-ras oncogene interferes with the expression of cyclic AMP-dependent promoters
125. The v-Ki-Ras oncogene alters cAMP nuclear signaling by regulating the location and the expression of cAMP-dependent protein kinase IIbeta
126. Regulation of protein kinase C
127. Regulation of ion channels by inositol trisphosphate and diacylglycerol
128. Inositol trisphosphate, a novel second messenger in cellular signal transduction
129. Protein kinase-C activation during thyrotropin-stimulated proliferation of rat FRTL-5 thyroid cells
130. Activation of phospholipase D in FRTL-5 thyroid cells by forskolin and dibutyryl-cyclic adenosine monophosphate
131. Thyroid-stimulating hormone activates phospholipase D in FRTL-5 thyroid cells via stimulation of protein kinase C
132. Species differences of the thyroid protein kinase C heterogeneity
133. Identification of protein kinase C and its multiple isoforms in FRTL-5 thyroid cells
134. Regulation of protein kinase C isoforms in FRTL-5 thyroid cells by TSH and phorbol ester
135. Signaling through protein kinase C
136. Protein kinase C involvement in apoptosis
137. Phorbol esters stimulate growth and inhibit differentiation in cultured thyroid cells
138. Stimulation of cell proliferation and inhibition of differentiation expression by tumor-promoting phorbol esters in dog thyroid cells in primary culture
139. Effects of ceramide and protein kinase C on the regulation of type I 5'-deiodinase in FRTL-5 rat thyroid cells
140. Reversible inhibition of a thyroid-specific trans-acting factor by Ras
141. Multiple mechanisms of interference between transformation and differentiation in thyroid cells
142. Acute effect of thyrotropin on phosphatidylinositol degradation and transient accumulation of diacylglycerol in isolated thyroid follicles
143. Thyrotropin and norepinephrine stimulate the metabolism of phosphoinositides in FRTL-5 thyroid cells
144. The role of phosphoinositide 3-kinase lipid products in cell function
145. Using structure to define the function of phosphoinositide 3-kinase family members
146. Oncogenes and signal transduction
147. Ras inhibits thyroglobulin expression but not cyclic adenosine monophosphate-mediated signaling in Wistar rat thyrocytes
148. A tyrosine kinase signaling pathway accounts for the majority of phosphatidylinositol 3,4,5-triphosphate formation in chemoattractant-stimulated human neutrophils
149. G-protein coupled receptor-mediated activation of PI 3-kinase in neutrophils
150. A G-protein beta gamma-subunit-responsive phosphoinositide 3-kinase activity in human platelet cytosol
151. Microinjection of the SH2 domain of the 85-kilodalton subunit of phosphatidylinositol 3-kinase inhibits insulin-induced DNA synthesis and c-fos expression
152. Specific activation of p85-p110 phosphatidylinositol 3'-kinase stimulates DNA synthesis by Ras- and p70 S6 kinase-dependent pathways
153. The phosphatidylinositol 3-kinase alpha is required for DNA synthesis induced by some, but not all, growth factors
154. Suppression of insulin-stimulated phosphatidylinositol 3-kinase activity by the beta3-adrenoceptor agonist CL316243 in rat adipocytes
155. A regulatory role for cAMP in phosphatidylinositol 3-kinase/p70 ribosomal S6 kinase-mediated DNA synthesis in platelet-derived-growth-factor-stimulated bovine airway smooth-muscle cells
156. Mechanism of activation and function of protein kinase B
157. PDK1, one of the missing links in insulin signal transduction
158. Lipid-regulated kinases: Some common themes at last
159. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region
160. Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families
161. Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily
162. The 70kDa S6 kinase: Regulation of a kinase with multiple roles in mitogenic signalling
163. The modular phosphorylation and activation of p70s6k
164. The 70kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Racl
165. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling
166. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras
167. Differential effects of cyclic adenosine 3',5'-monophosphate on p70 ribosomal S6 kinase
168. Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation
169. Somatostatin interferes with thyrotropin-induced G1-S transition mediated by PKA and PI3-K: Involvement of RhoA and cyclin E-CDK2 complexes
170. Ras pathways to cell cycle control and Cell transformation
171. Signal transduction from multiple Ras effectors
172. Ras-effector interactions, the problem of specificity
173. The GTPase super-family: A conserved switch for diverse cell functions
174. Ras-like GTP-ases
175. Hormone-dependent terminal differentiation in vitro of chicken erythroleukemia cells transformed by ts mutants of avian erythroblastosis virus
176. Temperature-sensitive expression of differentiation in transformed myoblasts
177. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation
178. Regulation of a collagen gene promoter by the product of viral mos oncogene
179. Molecular events involved in differentiation of thyroid follicular cells
180. Ha-ras interference with thyroid cell differentiation is associated with a down-regulation of thyroid transcription factor-1 phosphorylation
181. Differential effects of protein kinase A on Ras effector pathways
182. Thyrotropin-induced mitogenesis is Ras dependent but appears to bypass the Raf-dependent cytoplasmic kinase cascade
183. Mechanism of inhibition of Raf-1 by protein kinase A
184. Phosphorylation of mitogen-activated protein kinases is involved in the epidermal growth factor and phorbol ester, but not in the thyrotropin/cAMP, thyroid mitogenic pathway
185. Multiple Ras functions can contribute to mammalian cell transformation
186. A role for RalGDS and a novel Ras effector in the Ras-mediated inhibition of skeletal myogenesis
187. Plasma membrane recruitment of RalGDS is critical for Ras-dependent Ral activation
188. Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation
189. A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation
190. RalGDS functions in Ras- and cAMP-mediated growth stimulation
191. Cyclic AMP-dependent activation of Rap1b
192. Activation of the small G protein Rap1 in dog thyroid cells by both cAMP-dependent and -independent pathways
193. Microinjection of smg/rap1/Krev-1 p21 into Swiss 3T3 cells induces DNA synthesis and morphological changes
194. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3',5'-monophosphate
195. Inhibition by cAMP of Ras-dependent activation of Raf
196. Increasing cAMP attenuates activation of mitogen-activated protein kinase
197. RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts
198. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic
199. A family of cAMP-binding proteins that directly activate Rap-1
200. Rho GTPases and signaling networks
201. The Ras-related protein Cdc42Hs and bradykinin promote formation of peripheral actin microspikes and filopodia in Swiss 3T3 fibroblasts
202. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia
203. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1
204. The MAPK signaling cascade
205. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF
206. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation
207. An essential role for Rac in Ras transformation
208. A role for Rho in Ras transformation
209. Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation
210. A novel Cdc42Hs mutant induces cellular transformation
211. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors
212. Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes
213. cAMP-induced morphological changes are counteracted by the activated RhoA small GTPase and the Rho kinase ROKalpha
214. Newly synthesized Rho A, not Ras, is isoprenylated and translocated to membranes coincident with progression of the G1 to S phase of growth-stimulated rat FRTL-5 cells
215. Nucleotide sequence of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase, a glycoprotein of endoplasmic reticulum
216. Cell cycle progression and 3-hydroxy-3-methylglutaryl coenzyme A reductase are regulated by thyrotropin in FRTL-5 rat thyroid cells
217. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in FRTL-5 cells. I. Identification and characterization of a cyclic AMP-responsive element in the rat reductase promoter
218. Bridging Ral GTPase to Rho pathways
219. G1 phase progression: Cycling on cue
220. Cyclin-dependent regulation of G1 in mammalian fibroblasts
221. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts
222. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system
223. Novel mammalian cyclins (CYL genes) expressed during G1
224. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
225. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins
226. Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1
227. Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase
228. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein
229. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)
230. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization
231. Physical interaction of the retinoblastoma protein with human D cyclins
232. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
233. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4
234. D-type cyclin-dependent kinase activity in mammalian cells
235. Identification of G1 kinase activity for cdk6, a novel cyclin D partner
236. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins
237. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle
238. Association of human cyclin E with a periodic G1-S phase protein kinase
239. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
240. Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein
241. Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation
242. Identification of a substrate-targeting domain in cyclin E necessary for phosphorylation of the retinoblastoma protein
243. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes
244. Cyclin E-CDK2 is a regulator of p27Kip1
245. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27
246. A cdc2-like protein is involved in the initiation of DNA replication in Xenopus egg extracts
247. Cell cycle control of DNA replication by a homologue from human cells of the p34cdc2 protein kinase
248. Evidence that the G1-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes
249. Cell cycle control of DNA replication
250. Cyclin/Cdk-dependent initiation of DNA replication in a human cell-free system
251. Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry
252. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase
253. Thyrotropin induces G1 cyclin expression and accelerates G1 phase after insulin-like growth factor I stimulation in FRTL-5 cells
254. Geranylgeranylated rho small GTPase(s) are essential for the degradation of p27Kip1 and facilitate the progression from G1 to S phase in growth-stimulated rat FRTL-5 cells
255. Kip/Cip and Ink4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-b
256. p21-containing cyclin kinases exist in both active and inactive states
257. Inhibitors of mammalian G1 cyclin-dependent kinases
258. Differential modulation of G1 cyclins and the Cdk inhibitor p27kip1 by platelet-derived growth factor and plasma factors in density-arrested flbroblasts
259. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin
260. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes
261. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation
262. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
263. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle
264. Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (Go state) in fibroblasts
265. Ablation of Go alpha overrides G1 restriction point control through Ras/ERK/cyclin D1-CDK activities